India  

AstraZeneca sues US over Medicare drug price negotiation plans

IndiaTimes Friday, 25 August 2023
AstraZeneca has filed a lawsuit against the US government to prevent the Medicare health insurance plan from negotiating lower drug prices. The British drugmaker argues that the program would hinder the development of new medicines. AstraZeneca's legal challenge aims to protect access to medicines for rare conditions.
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

Biden gives 1st remarks after unveiling drug price negotiations with Medicare [Video]

Biden gives 1st remarks after unveiling drug price negotiations with Medicare

Biden gives 1st remarks after unveiling drug price negotiations with Medicare

Credit: Rumble     Duration: 10:21Published